Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Yandian

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Kidney Journal|August 2, 2023
Future landscape for the management of membranous nephropathyFernando Caravaca-Fontán, Federico Yandian, Fernando C Fervenza
Current Opinion in Nephrology and Hypertension|November 8, 2024
Updated diagnostic and therapeutic management for membranous nephropathyFernando Caravaca-Fontán, Federico Yandian, Fernando C Fervenza
Advances in Kidney Disease and Health|February 11, 2026
Complement 3 Glomerulopathy Revisited: Bridging Pathogenesis and Therapy in the New EraFederico Yandian, Fernando C Fervenza, Fernando Caravaca-Fontán
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 8, 2025
Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next GenerationFederico Yandian, Sanjeev Sethi, Fernando C Fervenza, et al.
Kidney360|October 25, 2024
Antimalarials in Lupus Nephritis: How Strong Is the Evidence?Fernando Caravaca-Fontán, Federico Yandian, Ladan Zand, et al.
Kidney International Reports|February 12, 2024
Kidney Diseases Associated With Inflammatory Bowel Disease: Impact of Chronic Histologic Damage, Treatments, and OutcomesFederico Yandian, Fernando Caravaca-Fontán, Loren P Herrera Hernandez, et al.
Kidney International|October 5, 2023
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Mayo Clinic Proceedings|October 7, 2023
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel ClassificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Kidney Journal|August 2, 2023
Future landscape for the management of membranous nephropathyFernando Caravaca-Fontán, Federico Yandian, Fernando C Fervenza
Current Opinion in Nephrology and Hypertension|November 8, 2024
Updated diagnostic and therapeutic management for membranous nephropathyFernando Caravaca-Fontán, Federico Yandian, Fernando C Fervenza
Advances in Kidney Disease and Health|February 11, 2026
Complement 3 Glomerulopathy Revisited: Bridging Pathogenesis and Therapy in the New EraFederico Yandian, Fernando C Fervenza, Fernando Caravaca-Fontán
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 8, 2025
Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next GenerationFederico Yandian, Sanjeev Sethi, Fernando C Fervenza, et al.
Kidney360|October 25, 2024
Antimalarials in Lupus Nephritis: How Strong Is the Evidence?Fernando Caravaca-Fontán, Federico Yandian, Ladan Zand, et al.
Kidney International Reports|February 12, 2024
Kidney Diseases Associated With Inflammatory Bowel Disease: Impact of Chronic Histologic Damage, Treatments, and OutcomesFederico Yandian, Fernando Caravaca-Fontán, Loren P Herrera Hernandez, et al.
Kidney International|October 5, 2023
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Mayo Clinic Proceedings|October 7, 2023
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel ClassificationSanjeev Sethi, Laurence H Beck, Richard J Glassock, et al.
Pageof 1